Guillermo Ortí

8PUBLICATIONS
95CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)HaematologyRadiation therapyTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 26, 2026
Molecular Underpinnings and Prevalence of Donor Cell-Derived Hematologic Neoplasms among Spanish Transplantation Centers.

|Jul 17, 2026
Incidence, clinical risk factors, and biomarkers of SOS/VOD following allogeneic HSCT in adults. A real-life study by the Spanish group of HSCT and cell therapy (GETH-TC).

|Apr 10, 2026
Management of tyrosine kinase inhibitors and donor lymphocyte infusions post transplantation for chronic myeloid leukemia: a survey of contemporary practice on behalf of the chronic malignancies working party of the EBMT.

Alexandros Kanellopoulos, Linda Koster, Hugues de Lavallade

|Jul 30, 2025
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers.

Teresa Caballero-Velázquez, Javier Delgado Serrano, Lucía López-Corral

|Apr 09, 2025
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Guillermo Ortí, Guillaume Dachy, Charlotte E Graham

|Dec 11, 2024
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.

Virginia Escamilla-Gómez, Valentín García Gutiérrez, Patricia Alcalde-Mellado

Pageof 2

Frequent Collaborators

3 joint publications

Yves Chalandon

2 joint publications

Juan Montoro

2 joint publications

Pedro González-Sierra

2 joint publications

Joanna Drozd-Sokolowska